Physician
Ophthalmology
Alden Haun practices Ophthalmology. He went to Vanderbilt University School of Medicine. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAO)" and "Fellow (FACS)". Alden Haun has written publications. He has 1 publication published with PubMed. The lastest paper is: 'Exotropia and face turn in children with homonymous hemianopia.' He is registered with Medicare.
Publications
Schools
Vanderbilt University
PresbyterianSt Lukes Hospital
Vanderbilt University Eye Center
Procedures Preformed
- Anterior Vitrectomy
- Blepharoplasty
- Cataract Removal Surgery
- Contact Lens
- View All
Conditions Treated
- Acquired Coloboma
- Age-Related Macular Degeneration
- Anisocoria
- Anterior Ischemic Optic Neuropathy
- View All
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Options PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Golden Rule
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- POMCO Group
- Principal Life
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
- Fellow (FACS)
Education
-
Vanderbilt University
-
Vanderbilt University School of Medicine
Drug Facts
NPI NUMBER |
|
1316941842 |
NPPES Provider LastName |
|
HAUN |
NPPES Provider FirstName |
|
ALDEN |
NPPES Provider ZIPCode |
|
378036100 |
NPPES Provider State |
|
TN |
Specialty Description |
|
Ophthalmology |
Total Claim Count |
|
1847.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1316941842 |
Last Name Of The Provider |
HAUN |
First Name Of The Provider |
ALDEN |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog